Recombinant consensus interferon alpha (Beijing SL Pharmaceutical)

重组人新型复合干扰素α（双鹭药业）

Report date: 2022/02/21 10:04:13

Base Information

Drug NameRecombinant consensus interferon alpha (Beijing SL Pharmaceutical)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsHepatitis CHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesBeijing Sl Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Sl Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis CHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A